Pharmafile Logo
Pharmafocus logo
Advanced Search

Eyestem

Showing 2 posts of 2 posts found.

eye1

Eyestem secures $10m to advance cell therapy for advanced eye disease

August 13, 2025
Medical Communications, Research and Development Eyestem, Opthalmology, cell therapy, dry age-related macular degeneration, geographic atrophy

Indian cell therapy company, Eyestem Research, has raised $10m in a funding round to support development of its investigational retinal …

News

Successful trial results announced for potential rare eye disease treatment

April 14, 2025
Research and Development Eyestem, Opthalmology, age-related macular degeneration (AMD), biotech, cell therapy, eye disease

Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for …

News
The Gateway to Local Adoption Series

Latest content

Ofichem acquires US drug substance CDMO Kinentia

October 14, 2026

Jager-van Dijk is new Arletta Pharma Solutions CEO 

October 13, 2026

Tridem begins phase Ib trial of Parkinson’s disease vaccine

October 13, 2026

Bio-Techne opens GMP small-molecule manufacturing facility in Bristol

October 13, 2026

Trio become latest Symbiosis commercial additions

October 12, 2026